4//SEC Filing
Insys Therapeutics, Inc. 4
Accession 0001209191-16-136779
CIK 0001516479operating
Filed
Aug 11, 8:00 PM ET
Accepted
Aug 12, 3:40 PM ET
Size
8.2 KB
Accession
0001209191-16-136779
Insider Transaction Report
Form 4
Transactions
- Purchase
Common Stock
2016-08-12$18.57/sh+5,700$105,853→ 42,430,310 total(indirect: By Trust)
Holdings
- 31,982
Common Stock
- 56,288(indirect: By Partnership)
Common Stock
KAPOOR JOHN N
Director10% Owner
Transactions
- Purchase
Common Stock
2016-08-12$18.57/sh+5,700$105,853→ 42,430,310 total(indirect: By Trust)
Holdings
- 31,982
Common Stock
- 56,288(indirect: By Partnership)
Common Stock
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $18.4399 to $18.75, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
- [F2]By The John N. Kapoor Trust dated September 20, 1989.
- [F3]By EJ Financial/NEO Management, L.P. of which the reporting person is Managing General Partner.
Documents
Issuer
Insys Therapeutics, Inc.
CIK 0001516479
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001516479
Filing Metadata
- Form type
- 4
- Filed
- Aug 11, 8:00 PM ET
- Accepted
- Aug 12, 3:40 PM ET
- Size
- 8.2 KB